Advertisement

Topics

Novartis Reports Positive Results from Phase III Trial of Kisqali

16:00 EST 10 Nov 2017 | Drug Discovery Development

No additional safety signal was identified in the MONALEESA-7 study.
Contributed Author: 
Topics: 

Original Article: Novartis Reports Positive Results from Phase III Trial of Kisqali

NEXT ARTICLE

More From BioPortfolio on "Novartis Reports Positive Results from Phase III Trial of Kisqali"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...